![Cureus | Beneficial Effects of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Asthma: A Literature Review Cureus | Beneficial Effects of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Asthma: A Literature Review](https://assets.cureus.com/uploads/figure/file/448958/9ab947b02edc11edaa4451a294cadc5c-Potential-mechanisms-by-which-GLP-1rAs-affect-lung-function-in-Asthma.png)
Cureus | Beneficial Effects of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Asthma: A Literature Review
![Prehospital Management of Hypoglycemic Emergencies | The Journal of Collegiate Emergency Medical Services Prehospital Management of Hypoglycemic Emergencies | The Journal of Collegiate Emergency Medical Services](https://www.collegeems.com/wp-content/uploads/2019/02/Glucagon_Image.jpg)
Prehospital Management of Hypoglycemic Emergencies | The Journal of Collegiate Emergency Medical Services
![JCI - α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody–positive individuals JCI - α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody–positive individuals](https://dm5migu4zj3pb.cloudfront.net/manuscripts/156000/156243/medium/JCI156243.ga.jpg)
JCI - α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody–positive individuals
![Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife](https://iiif.elifesciences.org/lax/72919%2Felife-72919-fig4-v2.tif/full/,1500/0/default.jpg)
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife
![Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion - ScienceDirect Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124720307415-fx1.jpg)
Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion - ScienceDirect
![789 Important Things to Know About Gvoke HypoPen® (glucagon injection) — Juicebox Podcast and Arden's Day 789 Important Things to Know About Gvoke HypoPen® (glucagon injection) — Juicebox Podcast and Arden's Day](https://images.squarespace-cdn.com/content/v1/52a0933ce4b061dbb499e8aa/1668447993061-T55NX7HN82KJXUVKW6ZW/2022-11-10_Xeris_Podcast_2500x1221.jpg?format=1500w)
789 Important Things to Know About Gvoke HypoPen® (glucagon injection) — Juicebox Podcast and Arden's Day
![Mini-Dose Glucagon for Adults with Type 1 Diabetes: A Study to Assess the Efficacy and Safety of Mini-Dose Glucagon for Treatment of Non-Severe Hypoglycemia in Adults with Type 1 Diabetes - Diabetes Mini-Dose Glucagon for Adults with Type 1 Diabetes: A Study to Assess the Efficacy and Safety of Mini-Dose Glucagon for Treatment of Non-Severe Hypoglycemia in Adults with Type 1 Diabetes - Diabetes](https://clinicalresearch.itmat.upenn.edu/media/img/MGNS.jpg)
Mini-Dose Glucagon for Adults with Type 1 Diabetes: A Study to Assess the Efficacy and Safety of Mini-Dose Glucagon for Treatment of Non-Severe Hypoglycemia in Adults with Type 1 Diabetes - Diabetes
![Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife](https://iiif.elifesciences.org/lax/72919%2Felife-72919-fig1-v2.tif/full/,1500/0/default.jpg)
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife
![Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycaemia in type 1 diabetes - Virtual Meeting | EASD Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycaemia in type 1 diabetes - Virtual Meeting | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/806_607206/Slide1.jpg)
Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycaemia in type 1 diabetes - Virtual Meeting | EASD
![Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife](https://iiif.elifesciences.org/lax/72919%2Felife-72919-fig2-v2.tif/full/1500,/0/default.jpg)